Recent studies have highlighted NAT10’s involvement in pathological conditions, particularly cancer, where its dysregulation promotes tumor proliferation, metastasis, and therapy resistance by stabilizing oncogenic transcripts [27, 28]. The gene discussed is NAT10; the disease is neoplasm.